je.st
news
Tag: months
Get 4 Months of Google Play Music for Free
2016-07-05 18:08:21| PC Magazine Software Product Guide
Google's YouTube Red platform is also included, saving new users $40.
First 6 months of 2016 hottest ever recorded in New Zealand
2016-07-04 08:30:00| Climate Ark Climate Change & Global Warming Newsfeed
Associated Press: Ski fields are struggling to open and winter electricity consumption is down in New Zealand after the first six months of 2016 proved to be the hottest start to a year that scientists have ever recorded. Temperatures in the South Pacific nation were 1.4 degrees Celsius (2.5 Fahrenheit) above the long-term average for the first half of the year, according to the government-funded National Institute of Water and Atmospheric Research. That's the highest since record-keeping began more than a century...
Orange brand to remain in Kenya for 18 months
2016-06-14 02:00:00| Total Telecom industry news
Former Orascom CFO to lead Helios Investment Partners' bid to turn around Kenyan mobile operator.
Tags: months
brand
remain
orange
Less than 2 months in, car2go has more than 78K customers in Chongqing
2016-06-07 19:56:44| Green Car Congress
Tags: in
than
months
customers
Updated Findings from KEYNOTE-012 for KEYTRUDA (pembrolizumab) Show Continued Benefit in Response Rates and Duration of Response Lasting Up to 30 Months in Patients with Previously Treated Recurrent or Metastatic Head and Neck Cancer
2016-06-06 14:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Response Rates from KEYNOTE-055 Show Nearly One in Five Patients Responding with KEYTRUDA; Results Confirm Findings from KEYNOTE-012 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced new data with KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, as a monotherapy from two studies (KEYNOTE-012 and KEYNOTE-055) in heavily pre-treated patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Data are being presented at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558An Phan, 908-255-6325orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] next »